Statin use and cognitive impairment in patients with type 1 diabetes: An observational study

Clinical Neuropharmacology

Volumn 39, Issue 4, 2016, Pages 182-187

  Moryś, Joanna M ^a   Kozera, Grzegorz M ^b   Neubauer Geryk, Jolanta ^a   Kruszewski, Piotr ^a   Wolnik, Bogumił ^a   Nyka, Walenty M ^a   Bieniaszewski, Leszek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

cognitive impairment; statin; type 1 diabetes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATTENTION; BLOCK DESIGN TEST; BRAIN DAMAGE TEST; COGNITIVE DEFECT; COGNITIVE FUNCTION TEST; CONTROLLED ORAL WORD ASSOCIATION TEST; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIGIT SPAN TEST; DRUG EFFECT; DRUG USE; EXECUTIVE FUNCTION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOM ERROR; REY OSTERRIETH COMPLEX FIGURE TEST; TRAIL MAKING TEST; WECHSLER ADULT INTELLIGENCE SCALE; WISCONSIN CARD SORTING TEST; ADOLESCENT; AGED; CHI SQUARE DISTRIBUTION; COGNITION DISORDERS; COHORT ANALYSIS; COMPLICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSIOLOGY; POLAND; PROBLEM SOLVING; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; POLAND; PROBLEM SOLVING; YOUNG ADULT;

EID: 84962440850     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0000000000000158     Document Type: Article

References (45)

1. Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5(1):64-74.
2. Brands AM, Biessels GJ, de Haan EH, et al. The effects of type 1 diabetes on cognitive performance: a meta-Analysis. Diabetes Care 2005;28(3): 726-735.
3. Deary IJ, Crawford JR, Hepburn DA, et al. Severe hypoglycemia and intelligence in adult patients with insulin-Treated diabetes. Diabetes 1993; 42(2):341-344.
4. Ryan CM, Williams TM, Orchard TJ, et al. Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes 1992;41(1):107-113.
5. Sachon C, Grimaldi A, Digy JP, et al. Cognitive function, insulin-dependent diabetes and hypoglycaemia. J InternMed 1992;231(5):471-475.
6. Wredling R, Levander S, Adamson U, et al. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia 1990;33(3):152-157.
7. Lawson JS, Erdahl DL, Monga TN, et al. Neuropsychological function in diabetic patients with neuropathy. Br J Psychiatry 1984;145:263-268.
8. McCrimmon RJ, RyanCM, Frier BM. Diabetes and cognitive dysfunction. Lancet 2012;379(9833):2291-2299.
9. Auer RN. Hypoglycemic brain damage. Metab Brain Dis 2004;19(3-4): 169-175.
10. Malone JI, Hanna S, Saporta S, et al. Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatr Diabetes 2008;9(6):531-539.
11. Sima AA, Kamiya H, Li ZG. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 2004; 490(1-3):187-197.
12. HoffmanWH, ArtlettCM, ZhangW, et al. Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis. Brain Res 2008;1238:154-162.
13. Li ZG, Sima AA. C-peptide and central nervous system complications in diabetes. Exp Diabesity Res 2004;5(1):79-90.
14. Ba-Tin L, Strike P, Tabet N. Diabetic peripheral microvascular complications: relationship to cognitive function. Cardiovasc Psychiatry Neurol 2011;2011:723434.
15. Jacobson AM, Ryan CM, Cleary PA, et al. Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. Diabetologia 2011;54(2):245-255.
16. Ferguson SC, Blane A, Perros P, et al. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 2003;52(1):149-156.
17. Pretnar-Oblak J, Sabovic M, Sebestjen M, et al. Influence of atorvastatin treatment on L-Arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions. Stroke 2006;37(10): 2540-2545.
18. Sterzer P, Meintzschel F, Rosler A, et al. Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease. Stroke 2001;32(12):2817-2820.
19. McGuinness B, O'Hare J, Craig D, et al. Statins for the treatment of dementia. Cochrane Database Syst Rev 2010;4(8):CD007514.
20. Zandi PP, Sparks DL, Khachaturian AS, et al. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry 2005;62(2):217-224.
21. Rea TD, Breitner JC, Psaty BM, et al. Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol 2005;62(7): 1047-1051.
22. Swiger KJ, Manalac RJ, Blumenthal RS, et al. Statins and cognition: a systematic review and meta-Analysis of short-And long-Term cognitive effects. Mayo Clin Proc 2013;88(11):1213-1221.
23. US Food and Drug Administration. New FDA drug safety communication: important safety label changes to cholesterol-lowering statin drugs. 2013. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm. Accessed April 10, 2015.
24. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59(8):750-755.
25. Fei M, Yan Ping Z, Ru Juan M, et al. Risk factors for dementia with type 2 diabetes mellitus among elderly people in China. Age Ageing 2013; 42(3):398-400.
26. Berk-Planken I, de Konig I, Stolk R, et al. Atorvastatin, diabetic dyslipidemia, and cognitive functioning. Diabetes Care 2002;25(7): 1250-1251.
27. Salthouse TA What cognitive abilities are involved in trail-making performance? Intelligence 2011;39(4):222-232
28. Lezak MD, Howieson DB, Bigler ED, et al. Neuropsychological Assessment. 5th ed. New York, NY Oxford University Press; 2012.
29. Strauss E, Sherman EMS, Spreen O. ACompendium of Neuropsychological Tests Administration, Norms, and Commentary. 3rd ed. New York, NY: Oxford University Press; 2006.
30. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361-370.
31. Miles WR, Root HF. Psychologic tests applied to diabetic patients. Arch Intern Med 1922;30:767-777.
32. Ryan CM, Williams TM, Finegold DN, et al. Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 1993;36(4):329-334.
33. Ryan CM, GeckleMO, Orchard TJ. Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro-And macrovascular complications. Diabetologia 2003;46(7):940-948.
34. Perantie DC, Lim A, Wu J, et al. Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes 2008;9(2):87-95.
35. Ohmann S, Popow C, Rami B, et al. Cognitive functions and glycemic control in children and adolescents with type 1 diabetes. Psychol Med 2010;40(1):95-103.
36. Northam EA, Lin A. Hypoglycaemia in childhood onset type 1 diabetes-part villain, but not the only one. Pediatr Diabetes 2010;11(2): 134-141.
37. Moheet AA, Seaquist ER. Diabetes and the brain-An overviewof existing knowledge and discussions and future implications. US Endocrinology 2010;6(1):28-32.
38. Kawamura T, Umemura T, Hotta N Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig 2012;3(5):413-423
39. Kuo HK, Jones RN, Milberg WP, et al. Effect of blood pressure and diabetes mellitus on cognitive and physical functions in older adults: a longitudinal analysis of the advanced cognitive training for independent and vital elderly cohort. J Am Geriatr Soc 2005;53(7):1154-1161.
40. Gallacher JE, Pickering J, Elwood PC, et al. Glucoregulation has greater impact on cognitive performance than macro-vascular disease in men with type 2 diabetes: data from the Caerphilly study. Eur J Epidemiol 2005;20(9):761-768.
41. Wysokinski A, Zboralski K, Orzechowska A, et al. Normalization of the Verbal Fluency Test on the basis of results for healthy subjects, patients with schizophrenia, patients with organic lesions of the chronic nervous system and patients with type 1 and 2 diabetes. Arch Med Sci 2010;6(3): 438-446.
42. Lobnig BM, Krömeke O, Optenhostert-Porst C, et al. Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications. Diabet Med 2006; 23(1):32-39.
43. National Institute for Health and Care Excellence. Statins for the prevention of cardiovascular events. 2006. Available at: http://www.nice. org.uk/ta94. Accessed April 10, 2015.
44. Solanki RK, Dubey V, Munshi D. Neurocognitive impairment and comorbid depression in patients of diabetes mellitus. Int J Diabetes Dev Ctries 2009;29(10):133-138.
45. Cox DJ, Kovatchev BP, Gonder-Frederick LA, et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 2005;28(1):71-77.